InSightec Ltd

2014/7/4 11:10


AsiaNet 57263

共同JBN 0749 (2014.7.4)

【台北(台湾)2014年7月4日PRN=共同JBN】台北医学大学と台北がんセンター(Taipei Medical University-Taipei Cancer Center、TMU-TCC)は4日、台北がんセンター(TCC)が痛みの激しい骨転移に苦しむ患者の生活の質を改善するため、新技術のExAblateを提供すると発表した。台北がんセンターは台北医学大学付属病院でがん患者にドアを開いてこのタイプの治療を提供する台湾で最初の放射線腫瘍治療施設である。






Taipei Cancer Center、 (02) 6636-9060、 http://www.cancertaipei.tw/



▽台北医学大学と台北がんセンター(Taipei Medical University-Taipei Cancer Center)について



インサイテック社(InSightec Ltd)はMR誘導集束超音波技術のパイオニア、世界リーダーである。GEヘルスケア(当時はGEメディカル・システムズ)とElbit Medical Imagingによって1999年に創立された同社の使命は自社のMR誘導集束超音波(MRgFUSを変革して臨床的に実行可能な技術にすることである。



Xen Mendelsohn Aderka

VP of Marketing



ソース: InSightec Ltd

Taipei Medical University-Taipei Cancer Center Offers a New and Noninvasive Treatment for Bone Cancer Pain


TAIPEI, Taiwan, July 4, 2014 /PRN=KYODO JBN/ --

    Taipei Medical University-Taipei Cancer Center (TMU-TCC) announced today

that its Taipei Cancer Center (TCC) is now offering a new technology, ExAblate,

to improve the quality of life of patients suffering from painful bone

metastases. Taipei Cancer Center, affiliated hospital of Taipei Medical

University, sets up the first radiation oncology clinic in Taiwan opening its

doors to cancer patients and offering this type of treatment.

    ExAblate is an MR guided focused ultrasound (MRgFUS) system, which combines

therapeutic acoustic ultrasound waves and continuous guidance and treatment

monitoring with an MRI. "We are excited to offer our patients a new and

noninvasive course of treatment," said Professor Jeng Fong Chiou, Vice

Superintendent of Taipei Cancer Center. "This treatment provides quick and

lasting pain relief without radiation and most patients have reported pain

relief within a few days", he emphasized.

    ExAblate, developed by InSightec (Israel), is the only US FDA approved

MRgFUS system (2012 for the indication of bone metastases related to pain

management). ExAblate treatments ensure a high rate of effectiveness with

minimal damage to surrounding tissue.

    "Taipei Cancer Center joins other world-class prestigious centers around

the world who are now offering patients innovative MR guided focused ultrasound

therapy for the benefit of Taiwan citizens," said Dr. Roni Yagel, Vice

President International Markets of InSightec, who was present at the site

inauguration. "We look forward to working with Taipei Cancer Center to lead the

way to offering non-invasive solutions for a wide variety of indications." he


    Bone metastases occur when cancer cells spread from their primary site to

other parts of the body. More than two-thirds of breast and prostate cancers,

for example, spread to the bones. Pain is the most severe symptom, for which

pain medications and palliative radiation therapy are the most common

treatments prescribed. However, up to 30% percent of patients either do not

respond to radiation therapy or are unable to undergo radiation for pain

relief. The US Journal of the National Cancer Institute recently published a

study confirming that MRgFUS can relieve pain and improve function in most

patients with bone tumors.

    For more information, please contact: For more information, please contact

the Taipei Cancer Center at (02) 6636-9060, http://www.cancertaipei.tw/

    The open access article may be read at


    About Taipei Medical University-Taipei Cancer Cente

    Taipei Medical University (TMU) is one of the largest health care systems

in Taiwan and includes a medical university and three hospitals: Taipei Medical

University Hospital, Wan Fang Hospital, and Shuang Ho Hospital. Altogether the

three hospitals have a total of more than 3,000 beds. Taipei Medical University

established the Taipei Cancer Center (TCC) in the beginning of 2012, the first

world-class cancer center in Taiwan that combines cancer research, training and

clinical treatment supported by experts from Taiwan and abroad. The Center is

dedicated to providing a full spectrum of services for adult and pediatric

oncology patients and their families.

    About InSightec

    InSightec Ltd. is the pioneer and global leader in MR guided focused

ultrasound technology. Founded in 1999 by GE Healthcare (then GE Medical

Systems) and Elbit Medical Imaging, its mission is to transform its MR guided

Focused Ultrasound (MRgFUS) into a clinically viable technology.


    Media Contacts


    Xen Mendelsohn Aderka

    VP of Marketing




    SOURCE: InSightec Ltd